Support of the Emory National Primate Research Center
埃默里国家灵长类动物研究中心的支持
基本信息
- 批准号:10844283
- 负责人:
- 金额:$ 16.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AIDS preventionAddressAffinityAnatomyAntibodiesAntibody ResponseAntigensB-LymphocytesBindingBiopsyBone MarrowCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCellsClinical TrialsConduct Clinical TrialsEpidemicFollow-Up StudiesGoalsGrantHIVHIV vaccineHIV-1HIV/AIDSHumanImmune responseImmunizationImmunohistochemistryInfection preventionInflammatoryIntramuscularKnock-in MouseLengthMacaca mulattaMeasuresMessenger RNAModified Vaccinia Virus AnkaraMucous MembraneMutateMutationOutcomePositioning AttributePreventionPrimatesProductionProteinsRNA vaccinationResearchRouteSIVSamplingScientistStructure of germinal center of lymph nodeT cell responseT-LymphocyteUnited States National Institutes of HealthVaccinationVaccinesViralVisualizationcoronavirus diseasedesignexperimental studygp160immunogenicityimprovedmouse modelneutralizing antibodynonhuman primatenovel vaccinesresponsesubcutaneoustissue resident memory T cellvaccination strategyvaccine deliveryvaccine developmentvaccine formulationvaccine strategy
项目摘要
Abstract
The overall goal of this supplement is to develop vaccine strategies that induce strong neutralizing antibody
response against HIV using mRNA and modified vaccinia Ankara (MVA) vaccine delivery platforms. To
address the specific goals of the supplement, we will utilize samples obtained from studies conducted in the
Emory Center for HIV/AIDS Vaccine and Cure Research consortium at the Emory National Primate Research
Center. We propose to use the BG505 MD39 SOSIP mRNA as our vaccine strategy to elicit bnAbs. We
hypothesize that BG505 MD39 mRNA delivered intramuscularly as either full length gp160 or truncated gp140
will induce HIV specific neutralizing antibodies with broad neutralization activity in rhesus macaques.
Additionally, we would like to explore the effect of heterologous SIV Gag/Pol mRNA prime and MVA boost on
the CD8 T cell response and evaluate how the route of immunization alters the ability of CD8 T cells to be
boosted by MVA. We propose two specific aims. In Aim 1, we will compare the immunogenicity of MD39 gp160
and gp140 mRNA IM immunization. In Aim 2, we will characterize the immune response induced through
heterologous mRNA prime and MVA boost and determine if the route of immunization effects the CD8 T cell
response elicited by MVA. By completion of these aims we hope to develop improved vaccination strategy
against HIV that can generate both neutralizing antibodies and T cells.
摘要
项目成果
期刊论文数量(760)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Progress in developing transgenic monkey model for Huntington's disease.
- DOI:10.1007/s00702-017-1803-y
- 发表时间:2018-03
- 期刊:
- 影响因子:0
- 作者:Snyder BR;Chan AWS
- 通讯作者:Chan AWS
Raised without a father: monoparental care effects over development, sexual behavior, sexual reward, and pair bonding in prairie voles.
没有父亲抚养长大:单亲照料对草原田鼠的发育、性行为、性奖励和配对关系的影响。
- DOI:10.1016/j.bbr.2021.113264
- 发表时间:2021-06-25
- 期刊:
- 影响因子:2.7
- 作者:Valera-Marín G;Young LJ;Camacho F;Paredes RG;Rodríguez VM;Díaz NF;Portillo W
- 通讯作者:Portillo W
p38MAPK guards the integrity of endosomal compartments through regulating necrotic death.
p38mapk通过调节坏死死亡来保护内体室的完整性。
- DOI:10.1038/s41598-022-20786-4
- 发表时间:2022-09-29
- 期刊:
- 影响因子:4.6
- 作者:Yao, Jia;Atasheva, Svetlana;Toy, Randall;Blanchard, Emmeline L.;Santangelo, Philip J.;Roy, Krishnendu;Mocarski, Edward S.;Shayakhmetov, Dmitry M.
- 通讯作者:Shayakhmetov, Dmitry M.
Oxytocin increases eye-gaze towards novel social and non-social stimuli.
催产素增加了人们对新型社会和非社会刺激的目光。
- DOI:10.1080/17470919.2018.1542341
- 发表时间:2019-10
- 期刊:
- 影响因子:2
- 作者:Eckstein M;Bamert V;Stephens S;Wallen K;Young LJ;Ehlert U;Ditzen B
- 通讯作者:Ditzen B
The Exceptional Vulnerability of Humans to Alzheimer's Disease.
- DOI:10.1016/j.molmed.2017.04.001
- 发表时间:2017-06
- 期刊:
- 影响因子:13.6
- 作者:Walker LC;Jucker M
- 通讯作者:Jucker M
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RAVI THADHANI其他文献
RAVI THADHANI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RAVI THADHANI', 18)}}的其他基金
PDE5i with Tadalafil Changes the Extent of Renal Damage (PITCH_ER)
PDE5i 与他达拉非一起改变肾损伤的程度 (PITCH_ER)
- 批准号:
8606587 - 财政年份:2013
- 资助金额:
$ 16.99万 - 项目类别:
Impact of vitamin D supplementation on cardiac structure and function
补充维生素 D 对心脏结构和功能的影响
- 批准号:
8268146 - 财政年份:2012
- 资助金额:
$ 16.99万 - 项目类别:
Bioavailable Vitamin D Redefines Vitamin D Deficiency
生物可利用维生素 D 重新定义维生素 D 缺乏症
- 批准号:
8331000 - 财政年份:2012
- 资助金额:
$ 16.99万 - 项目类别:
Impact of vitamin D supplementation on cardiac structure and function
补充维生素 D 对心脏结构和功能的影响
- 批准号:
8626441 - 财政年份:2012
- 资助金额:
$ 16.99万 - 项目类别:
Impact of vitamin D supplementation on cardiac structure and function
补充维生素 D 对心脏结构和功能的影响
- 批准号:
8431335 - 财政年份:2012
- 资助金额:
$ 16.99万 - 项目类别:
Impact of vitamin D supplementation on cardiac structure and function
补充维生素 D 对心脏结构和功能的影响
- 批准号:
9292464 - 财政年份:2012
- 资助金额:
$ 16.99万 - 项目类别:
Patient Oriented Studies of Vitamin D in Chronic Kidney Disease
维生素 D 在慢性肾脏病中的以患者为导向的研究
- 批准号:
8279507 - 财政年份:2012
- 资助金额:
$ 16.99万 - 项目类别:
Bioavailable Vitamin D Redefines Vitamin D Deficiency
生物可利用维生素 D 重新定义维生素 D 缺乏症
- 批准号:
8511620 - 财政年份:2012
- 资助金额:
$ 16.99万 - 项目类别:
Patient Oriented Studies of Vitamin D in Chronic Kidney Disease
维生素 D 在慢性肾脏病中的以患者为导向的研究
- 批准号:
9026599 - 财政年份:2012
- 资助金额:
$ 16.99万 - 项目类别:
Patient Oriented Studies of Vitamin D in Chronic Kidney Disease
维生素 D 在慢性肾脏病中的以患者为导向的研究
- 批准号:
8638000 - 财政年份:2012
- 资助金额:
$ 16.99万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 16.99万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 16.99万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 16.99万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 16.99万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 16.99万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 16.99万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 16.99万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 16.99万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 16.99万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 16.99万 - 项目类别:
Research Grant